Stock market crash: I’d invest £3k in these 2 cheap UK shares in an ISA today to get rich

Buying these two UK shares in an ISA today could lead to high long-term returns after the recent market crash, in my opinion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Buying cheap UK shares after the recent market crash could be a means of generating high returns in the long run. Low valuations today, plus a likely stock market recovery, could reward investors who can look beyond risks such as Brexit and the coronavirus pandemic.

With that in mind, here are two UK shares that appear to offer a potent mix of dividends, long-term growth potential and attractive valuations. Investing £3k, or any other amount, in them today could help to grow your ISA over the coming years.

GSK: appealing dividend stock after market crash

GSK (LSE: GSK) could offer income investing appeal after the market crash. The company has maintained its dividend thus far at a time when around half of its FTSE 100 peers have decided to cut or delay their shareholder payouts. As such, it could become a more popular income investing opportunity while it offers a yield of 4.8%. This could help to push its share price higher.

GSK’s recent half-year results showed that coronavirus has disrupted its vaccines business. However, it expects this challenge to ease during the second half of the year, while it continues to make good progress in its restructuring plans and in developing its pipeline. As such, it may be less affected by a weak economic outlook than many other UK shares, which could provide it with defensive characteristics.

Therefore, now could be the right time to buy a slice of the business after the recent market crash. It seems to offer a mix of income appeal, long-term growth potential and defensive characteristics that could equate to impressive total returns from what remains an attractive valuation.

SSE: a sound strategy and high yield

SSE (LSE: SSE) is another FTSE 100 stock that could offer an attractive dividend outlook. The company’s recent trading update stated that it plans to stick to its five-year dividend plan whereby it expects to increase dividends per share at a similar pace to inflation. This means that it currently yields around 6%, which could make it a popular income share among investors when many of its index peers are reducing their shareholder payouts.

As with many UK shares, coronavirus has impacted SSE’s financial performance. It has faced disruption across some of its businesses, which is a trend that could continue in the near term. However, its £7.5bn capital expenditure programme that is targeted towards low-carbon investments could help to deliver an improving long-term financial outlook for the business, I feel.

As such, it could offer a resilient long-term financial performance relative to other UK shares. Although there is a risk of a second market crash, SSE seems to have a sound strategy through which to deliver dividend growth in the coming years.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Peter Stephens owns shares of GlaxoSmithKline and SSE. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »